This analysis is based on information available up to January 29, 2025, and reflects the most recent data and analyst opinions on Gilead Sciences' stock outlook.

Our detailed analysis of Gilead Sciences’ upside post-inflation shock captures trends in the company’s stock during the turbulent market conditions seen over 2022.

Tesla stock has soared this week on easing ... He received his M.A. in journalism from The New School and his B.A. in history and political science from McGill ... Jay L Clendenin / Getty Images.

On Wednesday, RBC Capital Markets adjusted its outlook on Gilead Sciences (NASDAQ:GILD) stock, increasing the price target to $90 from the previous $84 while maintaining a Sector Perform rating.

BioHarvest Sciences (TSE:BHSC) has released an update.BioHarvest Sciences Inc. has issued 575,000 stock options to key stakeholders, including consultants, employees, and a director, with an ...

Cassava Sciences Inc.’s stock tumbled 85% Monday to put it on track for its biggest-ever one-day decline, after the clinical-stage biotech company said a trial of a treatment for mild to ...